Michael McFadden
Fortune : 87 539 $ au 31/05/2026
Fortune : 87 539 $ au 31/05/2026
Michael E.
McFadden is Chief Executive Officer & Director at Alpha Cognition, Inc. since 2021.
Formerly, Mr. McFadden was Chief Commercial Officer at MPOWERHealth LLC and Urovant Sciences Ltd. He was Chief Commercial Officer at Urovant Sciences, Inc. from 2018 to 2019.
He served as Senior Vice President-Commercial at Avanir Pharmaceuticals, Inc. from 2015 to 2017.
He was Senior Director-Managed Markets at Amylin Pharmaceuticals, Inc. from 2007 to 2010.
He worked as Director-State Purchasing at Pharmacia Corp.
from 2001 to 2003.
Mr. McFadden completed undergraduate studies at the University of Louisiana at Monroe and Northeast Louisiana University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALPHA COGNITION INC 0,06% | 24/04/2026 | 14 142 ( 0,06% ) | 87 539 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ALPHA COGNITION INC. | Directeur Général | 12/04/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies for urologic conditions | Corporate Officer/Principal | 01/11/2019 |
| UROVANT SCIENCES LTD. | Corporate Officer/Principal | 01/11/2019 |
| AVANIR PHARMACEUTICALS INC | Corporate Officer/Principal | 01/04/2017 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Corporate Officer/Principal | 01/04/2010 |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Corporate Officer/Principal | 01/01/2003 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
University of Louisiana at Monroe
University of Louisiana at Monroe Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeast Louisiana University
Northeast Louisiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies for urologic conditions | Health Technology |
Urovant Sciences Ltd.
Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for urologic conditions | Health Technology |
Alpha Cognition, Inc.
Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
MPOWERHealth LLC
MPOWERHealth LLC Medical/Nursing ServicesHealth Services Provides musculoskeletal healthcare solutions | Health Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national